NPI Details
Rajan Gulati, M.D is an internal medicine in Middletown, NY with 54 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Rajan Gulati, M.D NPI is 1275534000. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
111 MALTESE DR
MIDDLETOWN, NY
ZIP 10940-115
Phone: (845) 342-4774
Fax: (845) 818-7555
The NPI 1275534000 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Injection, gadoteridol, (prohance multipack), per ml (HCPCS:A9576)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Hemoglobin a1c level (HCPCS:83036)
- Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
- Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
- Vitamin d-3 level (HCPCS:82306)
- Magnesium level (HCPCS:83735)
- Screening 3d breast mammography (HCPCS:77063)
- Screening mammography (HCPCS:77067)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Uric acid level, blood (HCPCS:84550)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Folic acid level, serum (HCPCS:82746)
- Thyroxine (thyroid chemical), total (HCPCS:84436)
- Thyroid hormone evaluation (HCPCS:84479)
- Transitional care management services for problem of moderate complexity (HCPCS:99495)
- Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Ferritin (blood protein) level (HCPCS:82728)
- Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
- Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
- Assessment of emotional or behavioral problems (HCPCS:96127)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- X-ray of chest, 2 views (HCPCS:71046)
- Ct scan of chest without contrast (HCPCS:71250)
- Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
- Complete ultrasound scan of 1 breast (HCPCS:76641)
- Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
- Urinalysis, manual test (HCPCS:81002)
- Mri scan of lower spinal canal without contrast (HCPCS:72148)
- Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Lactate dehydrogenase (enzyme) level (HCPCS:83615)
- Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
- Glutamyltransferase (liver enzyme) level (HCPCS:82977)
- Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
- Urine microalbumin (protein) analysis (HCPCS:82044)
- Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
- Ultrasound scan of head and neck soft tissue (HCPCS:76536)
- Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
- Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
The enumeration date for this NPI number is 8/2/2005 and was last updated on 1/4/2018.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207P00000X | Emergency Medicine | | 133483 | NEW YORK | No |
| 2 | 207R00000X | Internal Medicine | | 133483 | NEW YORK | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 00798467 | MEDICAID | NEW YORK | |
